在高风险复发的VTE中,降低剂量与全剂量DOAC在症状复发方面没有差异,但在37个月后降低了出血
Conor Bell1, Stephanie Carlin1,
1McMaster University, Hamilton, Ontario, Canada (C.B., S.C.).
Annals of internal medicine
|June 2, 2025
概括
这项研究引入了一般内科,家庭医疗和全科医疗的新型公式,以及血液学方面的具体进展. 这些临床影响评级为评估医疗实践的有效性提供了一种新的定量方法.
科学领域:
- 一般的内科医学一般内科医学.
- 家庭练习 家庭练习
- 一般的做法一般的做法
- 血液学 血液学 血液学
背景情况:
- 目前的临床影响评估缺乏标准化的定量指标.
- 需要在初级保健和血液学等专业领域改进评估工具.
研究的目的:
- 开发和介绍新的数学公式来评估临床影响.
- 为评估一般内科,家庭医疗,全科医疗和血液学方面的表现提供一个框架.
主要方法:
- 基于既定的临床指南和结果制定定量指标.
- 将这些公式应用于特定领域的代表性临床场景.
主要成果:
- 介绍GIM/FP/GP和血液学的特殊公式,详细介绍在补充文本中.
- 证明这些公式在量化临床影响方面的潜在实用性.
结论:
- 拟议的配方为评估临床影响提供了一种新的定量方法.
- 这些指标可能会提高各种医疗学科的绩效评估和质量改进计划.
相关概念视频
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
43
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
43
Dosage Regimen: Fixed Dose
2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
932
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
932
Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K


